CD4 and infection: In the maintenance of the therapeutic response, studies suggest that allelic variants of HLA may be associated with post-ART immune failure; for example, having the HLA-B*57 allele impairs the recovery of CD4+ T cells during the first three years after the onset of ART, even though the allele provides a potential mechanism for epidemiological protection against infection (20).